A. Abdolahi, G. Acosta, F. J. Breslin, S. E. Hemby, and W. J. Lynch, Incubation of nicotine seeking is associated with enhanced protein kinase A-regulated signaling of dopamine-and cAMP-regulated phosphoprotein of 32 kDa in the insular cortex, Eur J Neurosci, vol.31, pp.733-774, 2010.

H. R. Alpert, G. N. Connolly, and L. Biener, A prospective cohort study challenging the effectiveness of population-based medical intervention for smoking cessation, Tob Control, vol.22, pp.32-39, 2013.

K. Anggadiredja, M. Nakamichi, T. Hiranita, H. Tanaka, Y. Shoyama et al., Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade, Neuropsychopharmacology, vol.29, pp.1470-1478, 2004.

C. Arevalo, R. De-miguel, and R. Hernandez-tristan, Cannabinoid effects on anxiety-related behaviours and hypothalamic neurotransmitters, Pharmacol Biochem Behav, vol.70, pp.123-154, 2001.

M. Arnone, J. Maruani, F. Chaperon, M. H. Thiebot, M. Poncelet et al., Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors, Psychopharmacology (Berl), vol.132, pp.104-110, 1997.

E. Artiges, E. Ricalens, S. Berthoz, M. O. Krebs, J. Penttila et al., Exposure to smoking cues during an emotion recognition task can modulate limbic fMRI activation in cigarette smokers, Addict Biol, vol.14, pp.469-77, 2009.

M. S. Barr, F. Farzan, V. C. Wing, T. P. George, P. B. Fitzgerald et al., Repetitive transcranial magnetic stimulation and drug addiction, Int Rev Psychiatry, vol.23, pp.454-66, 2011.

E. Bellamoli, P. Manganotti, R. P. Schwartz, C. Rimondo, M. Gomma et al., rTMS in the treatment of drug addiction: an update about human studies, Behav Neurol, 2013.

C. E. Beyer, J. M. Dwyer, M. J. Piesla, B. J. Platt, R. Shen et al., Depression-like phenotype following chronic CB1 receptor antagonism, Neurobiol Dis, vol.39, pp.148-55, 2010.

P. Bienkowski, P. Zatorski, A. Baranowska, D. Ryglewicz, and H. Sienkiewicz-jarosz, Insular lesions and smoking cessation after first-ever ischemic stroke: a 3-month follow-up, Neurosci Lett, vol.478, pp.161-165, 2010.

K. Blum, A. L. Chen, T. J. Chen, E. R. Braverman, J. Reinking et al., Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary, Theor Biol Med Model, vol.5, p.24, 2008.

K. R. Bonson, S. J. Grant, C. S. Contoreggi, J. M. Links, J. Metcalfe et al., Neural systems and cue-induced cocaine craving, Neuropsychopharmacology, vol.26, pp.376-86, 2002.

A. L. Brody, M. A. Mandelkern, E. D. London, A. R. Childress, G. S. Lee et al., Brain metabolic changes during cigarette craving, Arch Gen Psychiatry, vol.59, pp.1162-72, 2002.

A. L. Brody, M. A. Mandelkern, R. E. Olmstead, J. Jou, E. Tiongson et al., Neural substrates of resisting craving during cigarette cue exposure, Biol Psychiatry, vol.62, pp.642-51, 2007.

J. M. Bronstein, M. Tagliati, R. L. Alterman, A. M. Lozano, J. Volkmann et al., Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues, Arch Neurol, vol.68, p.165, 2011.
URL : https://hal.archives-ouvertes.fr/inserm-00593616

K. Cahill and M. Ussher, Cannabinoid type 1 receptor antagonists (rimonabant) for smoking cessation, Cochrane Database Syst Rev, vol.16, 2011.

A. P. Chambers, V. K. Vemuri, Y. Peng, J. T. Wood, T. Olszewska et al., A neutral CB1 receptor antagonist reduces weight gain in rat, Am J Physiol Regul Integr Comp Physiol, vol.293, pp.2185-93, 2007.

R. Christensen, P. K. Kristensen, E. M. Bartels, H. Bliddal, and A. Astrup, Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials, Lancet, vol.370, pp.1706-1719, 2007.

N. L. Cluny, A. P. Chambers, V. K. Vemuri, J. T. Wood, L. K. Eller et al., The neutral cannabinoid CB receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat, Pharmacol Biochem Behav, vol.97, pp.537-580, 2011.

N. L. Cluny, A. P. Chambers, V. K. Vemuri, J. T. Wood, L. K. Eller et al., The neutral cannabinoid CB(1) receptor antagonist AM4113 regulates body weight through changes in energy intake in the rat, Pharmacol Biochem Behav, vol.97, pp.537-580, 2011.

C. Cohen, G. Perrault, C. Voltz, R. Steinberg, and P. Soubrie, SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats, Behav Pharmacol, vol.13, pp.451-63, 2002.

C. Cohen, E. Kodas, and G. Griebel, CB1 receptor antagonists for the treatment of nicotine addiction, Pharmacol Biochem Behav, vol.81, pp.387-95, 2005.

C. Cohen, G. Perrault, G. Griebel, and P. Soubrie, Nicotine-associated cues maintain nicotine-seeking behavior in rats several weeks after nicotine withdrawal: reversal by the cannabinoid (CB(1)) receptor antagonist, Rimonabant (SR141716), Neuropsychopharmacology, vol.30, pp.145-55, 2005.

G. Colombo, R. Agabio, M. Fa, L. Guano, C. Lobina et al., Reduction of voluntary ethanol intake in ethanol-preferring sP rats by the cannabinoid antagonist SR-141716, Alcohol Alcohol, vol.33, pp.126-156, 1998.

G. Colombo, A. Orru, P. Lai, C. Cabras, P. Maccioni et al., The cannabinoid CB1 receptor antagonist, rimonabant, as a promising pharmacotherapy for alcohol dependence: preclinical evidence, Mol Neurobiol, vol.36, pp.102-114, 2007.

M. Contreras, F. Ceric, and F. Torrealba, Inactivation of the interoceptive insula disrupts drug craving and malaise induced by lithium, Science, vol.318, pp.655-663, 2007.

M. Contreras, P. Billeke, S. Vicencio, C. Madrid, G. Perdomo et al., A role for the insular cortex in long-term memory for context-evoked drug craving in rats, Neuropsychopharmacology, vol.37, pp.2101-2109, 2012.

A. D. Craig, How do you feel? Interoception: the sense of the physiological condition of the body, Nat Rev Neurosci, vol.3, pp.655-66, 2002.

A. R. Damasio, T. J. Grabowski, A. Bechara, H. Damasio, L. L. Ponto et al., Subcortical and cortical brain activity during the feeling of self-generated emotions, Nat Neurosci, vol.3, pp.1049-56, 2000.

D. Vries, T. J. Schoffelmeer, and A. N. , Cannabinoid CB1 receptors control conditioned drug seeking, Trends Pharmacol Sci, vol.26, pp.420-426, 2005.

D. Vries, T. J. Shaham, Y. Homberg, J. R. Crombag, H. Schuurman et al., A cannabinoid mechanism in relapse to cocaine seeking, Nat Med, vol.7, pp.1151-1155, 2001.

D. Vries, T. J. Homberg, J. R. Binnekade, R. Raaso, H. Schoffelmeer et al., Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats, Psychopharmacology (Berl), vol.168, pp.164-173, 2003.

D. Vries, T. J. De-vries, W. Janssen, M. C. Schoffelmeer, and A. N. , Suppression of conditioned nicotine and sucrose seeking by the cannabinoid-1 receptor antagonist SR141716A, Behav Brain Res, vol.161, pp.164-172, 2005.

J. P. Despres, A. Golay, and L. Sjostrom, Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia, N Engl J Med, vol.353, pp.2121-2155, 2005.

J. P. Despres, R. Ross, G. Boka, N. Almeras, and I. Lemieux, Effect of rimonabant on the high-triglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat. The ADAGIO-lipids trial, Arterioscler Thromb Vasc Biol, vol.29, pp.416-439, 2009.

D. Marzo and V. , Endocannabinoids: synthesis and degradation, Rev Physiol Biochem Pharmacol, vol.160, pp.1-24, 2006.

D. Marzo, V. Melck, D. Bisogno, T. , D. Petrocellis et al., Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action, Trends Neurosci, vol.21, pp.521-529, 1998.

D. Marzo, V. , D. Petrocellis, L. Bisogno, and T. , Endocannabinoids Part I: molecular basis of endocannabinoid formation, action and inactivation and development of selective inhibitors, Expert Opin Ther Targets, vol.5, pp.241-65, 2001.

D. Pietro, N. C. Mashhoon, Y. Heaney, C. Yager, L. M. Kantak et al., Role of dopamine D1 receptors in the prefrontal dorsal agranular insular cortex in mediating cocaine self-administration in rats, Psychopharmacology (Berl), vol.200, pp.81-91, 2008.

L. Diergaarde, T. Pattij, I. Poortvliet, F. Hogenboom, W. De-vries et al., Impulsive choice and impulsive action predict vulnerability to distinct stages of nicotine seeking in rats, Biol Psychiatry, vol.63, pp.301-309, 2008.

D. G. Ehlinger, H. C. Bergstrom, C. G. Mcdonald, and R. F. Smith, Nicotine-induced dendritic remodeling in the insular cortex, Neurosci Lett, vol.516, pp.89-93, 2012.

J. M. Engelmann, F. Versace, J. D. Robinson, J. A. Minnix, C. Y. Lam et al., Neural substrates of smoking cue reactivity: a meta-analysis of fMRI studies, Neuroimage, vol.60, pp.252-62, 2012.

L. Fattore, P. Fadda, and W. Fratta, Endocannabinoid regulation of relapse mechanisms, Pharmacol Res, vol.56, pp.418-445, 2007.

M. C. Fiore, W. C. Bailey, S. J. Cohen, S. F. Dorfman, M. G. Goldstein et al., Public Health Service; 2000. Food and Drug Administration Endocrinologic and Metabolic Advisory. Briefing information, NDA 21-888 ZIMULTI (rimonabant)-Sanofi Aventis, vol.13, 2007.

B. Forget, M. Hamon, and M. H. Thiebot, Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats, Psychopharmacology (Berl), vol.181, pp.722-756, 2005.

B. Forget, K. M. Coen, L. Foll, and B. , Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration-comparison with CB(1) receptor blockade, Psychopharmacology (Berl), vol.205, pp.613-637, 2009.

B. Forget, A. Pushparaj, L. Foll, and B. , Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction, Biol Psychiatry, vol.68, pp.265-71, 2010.

T. R. Franklin, Z. Wang, J. Wang, N. Sciortino, D. Harper et al., Limbic activation to cigarette smoking cues independent of nicotine withdrawal: a perfusion fMRI study, Neuropsychopharmacology, vol.32, pp.2301-2310, 2007.

J. E. Gallate and I. S. Mcgregor, The motivation for beer in rats: effects of ritanserin, naloxone and SR 141716, Psychopharmacology (Berl), vol.142, pp.302-310, 1999.

J. E. Gallate, T. Saharov, P. E. Mallet, and I. S. Mcgregor, Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist, Eur J Pharmacol, vol.370, pp.233-273, 1999.

J. E. Gallate, P. E. Mallet, and I. S. Mcgregor, Combined low dose treatment with opioid and cannabinoid receptor antagonists synergistically reduces the motivation to consume alcohol in rats, Psychopharmacology (Berl), vol.173, pp.210-216, 2004.

H. Garavan, J. Pankiewicz, A. Bloom, J. K. Cho, L. Sperry et al., Cue-induced cocaine craving: neuroanatomical specificity for drug users and drug stimuli, Am J Psychiatry, vol.157, pp.1789-98, 2000.

C. R. Gerfen and R. M. Clavier, Neural inputs to the prefrontal agranular insular cortex in the rat: horseradish peroxidase study, Brain Res Bull, vol.4, pp.347-53, 1979.

P. S. Goldman-rakic, The cortical dopamine system: role in memory and cognition, Adv Pharmacol, vol.42, pp.707-718, 1998.

S. D. Grabus, B. R. Martin, S. E. Brown, and M. I. Damaj, Nicotine place preference in the mouse: influences of prior handling, dose and strain and attenuation by nicotinic receptor antagonists, Psychopharmacology (Berl), vol.184, pp.456-63, 2006.

J. Haller, B. Varga, C. Ledent, and T. F. Freund, CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents, Behav Pharmacol, vol.15, pp.299-304, 2004.

C. Hamani and Y. Temel, Deep brain stimulation for psychiatric disease: contributions and validity of animal models, Sci Transl Med, vol.4, pp.142-150, 2012.

C. Hampp, A. G. Hartzema, and T. L. Kauf, Cost-utility analysis of rimonabant in the treatment of obesity, Value Health, vol.11, pp.389-99, 2008.

S. G. Hardy, Analgesia elicited by prefrontal stimulation, Brain Res, vol.339, pp.281-285, 1985.

E. V. Harel, A. Zangen, Y. Roth, I. Reti, Y. Braw et al., H-coil repetitive transcranial magnetic stimulation for the treatment of bipolar depression: an add-on, safety and feasibility study, World J Biol Psychiatry, vol.12, pp.119-145, 2011.

E. V. Harel, L. Rabany, L. Deutsch, Y. Bloch, A. Zangen et al., H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: an 18-week continuation safety and feasibility study, World J Biol Psychiatry, 2012.

J. Hodge, J. P. Bow, K. S. Plyler, V. K. Vemuri, A. Wisniecki et al., The cannabinoid CB1 receptor inverse agonist AM 251 and antagonist AM 4113 produce similar effects on the behavioral satiety sequence in rats, Behav Brain Res, vol.193, pp.298-305, 2008.

J. A. Hollander, Q. Lu, M. D. Cameron, T. M. Kamenecka, and P. J. Kenny, Insular hypocretin transmission regulates nicotine reward, Proc Natl Acad Sci U S A, vol.105, pp.19480-19485, 2008.

H. Houchi, D. Babovic, O. Pierrefiche, C. Ledent, M. Daoust et al., CB(1) receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors, Neuropsychopharmacology, vol.30, pp.339-388, 2005.
URL : https://hal.archives-ouvertes.fr/inserm-00116578

B. L. Hungund, I. Szakall, A. Adam, B. S. Basavarajappa, and C. Vadasz, Cannabinoid CB1 receptor knockout mice exhibit markedly reduced voluntary alcohol consumption and lack alcohol-induced dopamine release in the nucleus accumbens, J Neurochem, vol.84, pp.698-704, 2003.

A. C. Janes, D. A. Pizzagalli, S. Richardt, B. De, S. Chuzi et al., Brain reactivity to smoking cues prior to smoking cessation predicts ability to maintain tobacco abstinence, Biol Psychiatry, vol.67, pp.722-731, 2010.

Z. Justinova, P. Munzar, L. V. Panlilio, S. Yasar, G. H. Redhi et al., Blockade of THC-seeking behavior and relapse in monkeys by the cannabinoid CB(1)-receptor antagonist rimonabant, Neuropsychopharmacology, vol.33, pp.2870-2877, 2008.

E. A. Jutkiewicz, V. K. Vemuri, and J. Bergman, Pro-depressant-like effects of CB1 receptor inverse agonists/antagonists in male Sprague-Dawley rats, Meeting Abstract Supplement) 581.7, 2010.

C. D. Kilts, R. E. Gross, T. D. Ely, and K. P. Drexler, The neural correlates of cue-induced craving in cocaine-dependent women, Am J Psychiatry, vol.161, pp.233-274, 2004.

J. Kuhn, R. Bauer, S. Pohl, D. Lenartz, W. Huff et al., Observations on unaided smoking cessation after deep brain stimulation of the nucleus accumbens, Eur Addict Res, vol.15, pp.196-201, 2009.

T. Lancaster, L. Stead, and K. Cahill, An update on therapeutics for tobacco dependence, Expert Opin Pharmacother, vol.9, pp.15-22, 2008.

L. Foll, B. George, and T. P. , Treatment of tobacco dependence: integrating recent progress into practice, Can Med Assoc J, vol.177, pp.1373-80, 2007.

L. Foll, B. Goldberg, and S. R. , Rimonabant, a CB 1 antagonist, blocks nicotine-conditioned place preferences, Neuroreport, vol.15, pp.2139-2182, 2004.

L. Foll, B. Goldberg, and S. R. , Cannabinoid CB 1 receptor antagonists as promising new medications for drug dependence, J Pharmacol Exp Ther, vol.312, pp.875-83, 2005.

L. Foll, B. Forget, B. Aubin, H. J. Goldberg, and S. R. , Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies, Addict Biol, vol.13, pp.239-52, 2008.

L. Foll, B. Gorelick, D. A. Goldberg, and S. R. , The future of endocannabinoid-oriented clinical research after CB1 antagonists, Psychopharmacology (Berl), vol.205, pp.171-175, 2009.

L. Strat, Y. Rehm, J. , L. Foll, and B. , How generalisable to community samples are clinical trial results for treatment of nicotine dependence: a comparison of common eligibility criteria with respondents of a large representative general population survey, Tob Control, vol.20, pp.338-381, 2011.

J. H. Lee, Y. Lim, B. K. Wiederhold, and S. J. Graham, A functional magnetic resonance imaging (FMRI) study of cue-induced smoking craving in virtual environments, Appl Psychophysiol Biofeedback, vol.30, pp.195-204, 2005.

C. Lerman, M. G. Lesage, K. A. Perkins, S. O. Siegel, S. J. Benowitz et al., Translational research in medication development for nicotine dependence, Nat Rev Drug Discov, vol.6, pp.746-62, 2007.

Y. Levkovitz, Y. Roth, E. V. Harel, Y. Braw, A. Sheer et al., A randomized controlled feasibility and safety study of deep transcranial magnetic stimulation, Clin Neurophysiol, vol.118, pp.2730-2774, 2007.

Y. Levkovitz, E. V. Harel, Y. Roth, Y. Braw, D. Most et al., Deep transcranial magnetic stimulation over the prefrontal cortex: evaluation of antidepressant and cognitive effects in depressive patients, Brain Stimul, vol.2, pp.188-200, 2009.

C. L. Limebeer, V. K. Vemuri, H. Bedard, S. T. Lang, K. P. Ossenkopp et al., Inverse agonism of cannabinoid CB1 receptors potentiates LiCl-induced nausea in the conditioned gaping model in rats, Br J Pharmacol, vol.161, pp.336-385, 2010.

M. Luijten, D. J. Veltman, W. Van-den-brink, R. Hester, M. Field et al., Neurobiological substrate of smoking-related attentional bias, Neuroimage, vol.54, pp.2374-81, 2011.

M. Luijten, D. A. O'connor, S. Rossiter, I. H. Franken, and R. Hester, Effects of reward and punishment on brain activations associated with inhibitory control in cigarette smokers, Addiction, vol.108, pp.1969-78, 2013.

M. Mantione, W. Van-de-brink, P. R. Schuurman, and D. Denys, Smoking cessation and weight loss after chronic deep brain stimulation of the nucleus accumbens: therapeutic and research implications: case report, Neurosurgery, 2010.

M. Margeta-mitrovic, I. Mitrovic, R. C. Riley, L. Y. Jan, and A. I. Basbaum, Immunohistochemical localization of GABA(B) receptors in the rat central nervous system, J Comp Neurol, vol.405, pp.299-321, 1999.

U. Maskos, B. E. Molles, S. Pons, M. Besson, B. P. Guiard et al., Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors, Nature, vol.436, pp.103-110, 2005.
URL : https://hal.archives-ouvertes.fr/pasteur-00162546

D. Mcbride, S. P. Barrett, J. T. Kelly, A. Aw, and A. Dagher, Effects of expectancy and abstinence on the neural response to smoking cues in cigarette smokers: an fMRI study, Neuropsychopharmacology, vol.31, pp.2728-2766, 2006.

F. J. Mcclernon, F. B. Hiott, S. A. Huettel, and J. E. Rose, Abstinence-induced changes in self-report craving correlate with event-related FMRI responses to smoking cues, Neuropsychopharmacology, vol.30, pp.1940-1947, 2005.

I. S. Mcgregor, C. N. Issakidis, and G. Prior, Aversive effects of the synthetic cannabinoid CP 55,940 in rats, Pharmacol Biochem Behav, vol.53, pp.657-64, 1996.

P. J. Mclaughlin, K. Winston, L. Swezey, A. Wisniecki, J. Aberman et al., The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats, Behav Pharmacol, vol.14, pp.583-591, 2003.

P. J. Mclaughlin, K. M. Winston, C. L. Limebeer, L. A. Parker, A. Makriyannis et al., The cannabinoid CB1 antagonist AM 251 produces food avoidance and behaviors associated with nausea but does not impair feeding efficiency in rats, Psychopharmacology (Berl), vol.180, pp.286-93, 2005.

R. Mechoulam, E. Fride, D. Marzo, and V. Endocannabinoids, Eur J Pharmacol, vol.359, pp.1-18, 1998.

L. V. Moran, H. Sampath, E. A. Stein, and L. E. Hong, Insular and anterior cingulate circuits in smokers with schizophrenia, Schizophr Res, vol.142, pp.223-232, 2012.

H. Myrick, R. F. Anton, X. Li, S. Henderson, D. Drobes et al., Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving, Neuropsychopharmacology, vol.29, pp.393-402, 2004.

M. Naassila, O. Pierrefiche, C. Ledent, and M. Daoust, Decreased alcohol self-administration and increased alcohol sensitivity and withdrawal in CB1 receptor knockout mice, Neuropharmacology, vol.46, pp.243-53, 2004.
URL : https://hal.archives-ouvertes.fr/inserm-00746177

N. H. Naqvi and A. Bechara, The hidden island of addiction: the insula, Trends Neurosci, vol.32, pp.56-67, 2009.

N. H. Naqvi and A. Bechara, The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making, Brain Struct Funct, vol.214, pp.435-50, 2010.

N. H. Naqvi, D. Rudrauf, H. Damasio, and A. Bechara, Damage to the insula disrupts addiction to cigarette smoking, Science, vol.315, pp.531-535, 2007.

M. Navarro, E. Hernandez, R. M. Munoz, I. Del-arco, M. A. Villanua et al., Acute administration of the CB1 cannabinoid receptor antagonist SR 141716A induces anxiety-like responses in the rat, Neuroreport, vol.8, pp.491-497, 1997.

P. T. Ohara, A. Granato, T. M. Moallem, B. R. Wang, Y. Tillet et al., Dopaminergic input to GABAergic neurons in the rostral agranular insular cortex of the rat, J Neurocytol, vol.32, pp.131-172, 2003.
URL : https://hal.archives-ouvertes.fr/hal-02680449

P. Pacher, S. Batkai, and G. Kunos, The endocannabinoid system as an emerging target of pharmacotherapy, Pharmacol Rev, vol.58, pp.389-462, 2006.

M. P. Paulus and M. B. Stein, An insular view of anxiety, Biol Psychiatry, vol.60, pp.383-390, 2006.

M. P. Paulus, S. F. Tapert, and M. A. Schuckit, Neural activation patterns of methamphetaminedependent subjects during decision making predict relapse, Arch Gen Psychiatry, vol.62, pp.761-769, 2005.

D. Piomelli, The molecular logic of endocannabinoid signalling, Nat Rev Neurosci, vol.4, pp.873-84, 2003.

D. Piomelli, The endocannabinoid system: a drug discovery perspective, Curr Opin Investig Drugs, vol.6, pp.672-681, 2005.

D. Piomelli, A. Giuffrida, A. Calignano, and F. Rodriguez-de-fonseca, The endocannabinoid system as a target for therapeutic drugs, Trends Pharmacol Sci, vol.21, pp.218-242, 2000.

M. Poncelet, J. Maruani, R. Calassi, and P. Soubrie, Overeating, alcohol and sucrose consumption decrease in CB1 receptor deleted mice, Neurosci Lett, vol.343, pp.216-224, 2003.

M. N. Potenza, K. I. Hong, C. M. Lacadie, R. K. Fulbright, K. L. Tuit et al., Neural correlates of stress-induced and cue-induced drug craving: influences of sex and cocaine dependence, Am J Psychiatry, vol.169, pp.406-420, 2012.

A. Pushparaj, C. Hamani, W. Yu, D. S. Shin, B. Kang et al., Electrical stimulation of the insular region attenuates nicotine-taking and nicotine-seeking behaviors, Neuropsychopharmacology, vol.38, pp.690-698, 2013.

N. A. Rigotti, D. Gonzales, L. C. Dale, D. Lawrence, and Y. Chang, A randomized controlled trial of adding the nicotine patch to rimonabant for smoking cessation: efficacy, safety and weight gain, Addiction, vol.104, pp.266-76, 2009.

M. Rinaldi-carmona, F. Barth, C. Congy, S. Martinez, D. Oustric et al., SR147778, a new potent and selective antagonist of the CB1 cannabinoid receptor. Biochemical and pharmacological characterization, J Pharmacol Exp Ther, vol.310, pp.905-919, 2004.

R. J. Rodgers, P. M. Evans, and A. Murphy, Anxiogenic profile of AM-251, a selective cannabinoid CB1 receptor antagonist, in plus-maze-naive and plus-maze-experienced mice, Behav Pharmacol, vol.16, pp.405-418, 2005.

F. Rodriguez-de-fonseca, A. J. Roberts, A. Bilbao, G. F. Koob, and M. Navarro, Cannabinoid receptor antagonist SR141716A decreases operant ethanol self administration in rats exposed to ethanol-vapor chambers, Zhongguo Yao Li Xue Bao, vol.20, pp.1109-1123, 1999.

O. Rosenberg, Y. Roth, M. Kotler, A. Zangen, and P. Dannon, Deep transcranial magnetic stimulation for the treatment of auditory hallucinations: a preliminary open-label study, Ann Gen Psychiatry, vol.10, p.3, 2011.

Y. Roth, A. Zangen, and M. Hallett, A coil design for transcranial magnetic stimulation of deep brain regions, J Clin Neurophysiol, vol.19, pp.361-70, 2002.

Y. Roth, A. Amir, Y. Levkovitz, and A. Zangen, Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils, J Clin Neurophysiol, vol.24, pp.31-39, 2007.

F. Rubboli, J. A. Court, C. Sala, C. Morris, E. Perry et al., Distribution of neuronal nicotinic receptor subunits in human brain, Neurochem Int, vol.25, pp.69-71, 1994.

D. Rucker, R. Padwal, S. K. Li, C. Curioni, and D. C. Lau, Long term pharmacotherapy for obesity and overweight: updated meta-analysis, BMJ, vol.335, pp.1194-1203, 2007.

S. Aventis, Sanofi-Aventis to discontinue all clinical trials with Rimonabant, 2008.

C. B. Saper, Convergence of autonomic and limbic connections in the insular cortex of the rat, J Comp Neurol, vol.210, pp.163-73, 1982.

A. J. Scheen, CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant, J Neuroendocrinol, vol.20, pp.139-185, 2008.

D. Scott and N. Hiroi, Deconstructing craving: dissociable cortical control of cue reactivity in nicotine addiction, Biol Psychiatry, vol.69, pp.1052-1061, 2011.

L. A. Sell, J. Morris, J. Bearn, R. S. Frackowiak, K. J. Friston et al., Activation of reward circuitry in human opiate addicts, Eur J Neurosci, vol.11, pp.1042-1050, 1999.

M. Shoaib, The cannabinoid antagonist AM251 attenuates nicotine self-administration and nicotine-seeking behaviour in rats, Neuropharmacology, vol.52, pp.438-482, 2008.

R. Sinha and C. S. Li, Imaging stress-and cue-induced drug and alcohol craving: association with relapse and clinical implications, Drug Alcohol Rev, vol.26, pp.25-31, 2007.

R. Sinha, C. Lacadie, P. Skudlarski, R. K. Fulbright, B. J. Rounsaville et al., Neural activity associated with stress-induced cocaine craving: a functional magnetic resonance imaging study, Psychopharmacology (Berl), vol.183, pp.171-80, 2005.

K. S. Sink, P. J. Mclaughlin, J. A. Wood, C. Brown, P. Fan et al., The novel cannabinoid CB(1) receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats, Neuropsychopharmacology, vol.33, pp.946-55, 2008.

K. S. Sink, K. N. Segovia, E. J. Nunes, L. E. Collins, V. K. Vemuri et al., Intracerebroventricular administration of cannabinoid CB1 receptor antagonists AM251 and AM4113 fails to alter food-reinforced behavior in rats, Psychopharmacology (Berl), vol.206, pp.223-255, 2009.

K. S. Sink, V. K. Vemuri, J. Wood, A. Makriyannis, and J. D. Salamone, Oral bioavailability of the novel cannabinoid CB1 antagonist AM6527: effects on food-reinforced behavior and comparisons with AM4113, Pharmacol Biochem Behav, vol.91, pp.303-309, 2009.

K. S. Sink, K. N. Segovia, J. Sink, P. A. Randall, L. E. Collins et al., Potential anxiogenic effects of cannabinoid CB1 receptor antagonists/inverse agonists in rats: comparisons between AM4113, AM251, and the benzodiazepine inverse agonist FG-7142, Eur Neuropsychopharmacol, vol.20, pp.112-134, 2010.

M. Solinas, L. V. Panlilio, K. Antoniou, L. A. Pappas, and S. R. Goldberg, The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats, J Pharmacol Exp Ther, vol.306, pp.93-102, 2003.

T. Sugiura and K. Waku, Cannabinoid receptors and their endogenous ligands, J Biochem, vol.132, pp.7-12, 2002.

T. Suhara, K. Nakayama, O. Inoue, H. Fukuda, M. Shimizu et al., D1 dopamine receptor binding in mood disorders measured by positron emission tomography, Psychopharmacology (Berl), vol.106, pp.14-22, 1992.

R. Suner-soler, A. Grau, M. E. Gras, S. Font-mayolas, Y. Silva et al., Smoking cessation 1 year poststroke and damage to the insular cortex, Stroke, vol.43, pp.131-137, 2012.

M. T. Sutherland, A. J. Carroll, B. J. Salmeron, T. J. Ross, L. E. Hong et al., Down-regulation of amygdala and insula functional circuits by varenicline and nicotine in abstinent cigarette smokers, Biol Psychiatry, vol.228, pp.43-55, 2013.

M. T. Sutherland, A. J. Carroll, B. J. Salmeron, T. J. Ross, and E. A. Stein, Insula's functional connectivity with ventromedial prefrontal cortex mediates the impact of trait alexithymia on state tobacco craving, Psychopharmacology (Berl), vol.228, pp.143-55, 2013.

G. Tanda, P. Munzar, and S. R. Goldberg, Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys, Nat Neurosci, vol.3, pp.1073-1077, 2000.

S. F. Tapert, G. G. Brown, M. V. Baratta, and S. A. Brown, fMRI BOLD response to alcohol stimuli in alcohol dependent young women, Addict Behav, vol.29, pp.33-50, 2004.

L. F. Van-gaal, A. M. Rissanen, A. J. Scheen, O. Ziegler, and S. Rossner, Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study, Lancet, vol.365, pp.1389-97, 2005.

S. R. Vorel, A. Bisaga, G. Mckhann, and H. D. Kleber, Insula damage and quitting smoking, Science, vol.317, pp.318-327, 2007.

G. J. Wang, N. D. Volkow, J. S. Fowler, P. Cervany, R. J. Hitzemann et al., Regional brain metabolic activation during craving elicited by recall of previous drug experiences, Life Sci, vol.64, pp.775-84, 1999.

Z. Wang, M. Faith, F. Patterson, K. Tang, K. Kerrin et al., Neural substrates of abstinence-induced cigarette cravings in chronic smokers, J Neurosci, vol.27, pp.14035-14075, 2007.

B. E. Wexler, C. H. Gottschalk, R. K. Fulbright, I. Prohovnik, C. M. Lacadie et al., Functional magnetic resonance imaging of cocaine craving, Am J Psychiatry, vol.158, pp.86-95, 2001.

. Who, , 2013.

Z. X. Xi, K. Spiller, A. C. Pak, J. Gilbert, C. Dillon et al., Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats, Neuropsychopharmacology, vol.33, pp.1735-1780, 2008.

X. Zhang, B. J. Salmeron, T. J. Ross, X. Geng, Y. Yang et al., Factors underlying prefrontal and insula structural alterations in smokers, Neuroimage, vol.54, pp.42-50, 2011.

X. Zhang, B. J. Salmeron, T. J. Ross, H. Gu, X. Geng et al., Anatomical differences and network characteristics underlying smoking cue reactivity, Neuroimage, vol.54, pp.131-172, 2011.